VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
GPAT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
GPATGP-Act III Acquisition Corp.
$11.07$398M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksGPATBalance Sheet

GP-Act III Acquisition Corp. (GPAT) Balance Sheet

5Y historyFree accessUpdated daily

The capital structure is increasingly reliant on sponsor-provided debt, which has risen to $515,000 as of 2026Q1, while retained earnings have eroded to a $15.0 million deficit.

GPAT Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'20
Total Current Assets206.51K188.11K675.36K3.31K3.76K0
Cash & Short-Term Investments------
Cash Only------
Short-Term Investments------
Accounts Receivable------
Days Sales Outstanding------
Inventory------
Days Inventory Outstanding------
Other Current Assets000000
Total Non-Current Assets311.9M309.18M296.8M526.93K1.06M287.93K
Property, Plant & Equipment000000
Fixed Asset Turnover------
Goodwill000000
Intangible Assets000000
Long-Term Investments1.23B309.18M296.74M000
Other Non-Current Assets------
Total Assets312.11M309.37M297.47M530.24K1.06M287.93K
Asset Turnover0.00x-----
Asset Growth %16.55%4%56001.91%-50.1%269.07%-
Total Current Liabilities1.22M634.61K631.61K628.18K1.15M266.91K
Accounts Payable000000
Days Payables Outstanding------
Short-Term Debt515K400K400K628.18K464.59K113.1K
Deferred Revenue (Current)0-----
Other Current Liabilities703.29K234.61K00681.99K149.83K
Current Ratio0.17x0.30x1.07x0.01x0.00x-
Quick Ratio0.17x0.30x1.07x0.01x0.00x-
Cash Conversion Cycle------
Total Non-Current Liabilities14.04M14.04M14.04M000
Long-Term Debt000000
Capital Lease Obligations0-----
Deferred Tax Liabilities0-----
Other Non-Current Liabilities------
Total Liabilities15.26M14.67M14.67M628.18K1.15M266.91K
Total Debt515K400K400K628.18K464.59K113.1K
Net Debt395.57K287.34K-83.57K626.97K462.83K113.1K
Debt / Equity0.00x0.00x0.00x--5.38x
Debt / EBITDA-0.56x-0.05x-116147.75x-
Net Debt / EBITDA-0.43x--0.01x-115708.25x-
Interest Coverage------
Total Equity296.85M294.7M282.8M-97.94K-83.9K21.03K
Equity Growth %17.16%4.2%288841.07%-16.73%-499.03%-
Book Value per Share10.3310.2515.45-0.00-0.000.00
Total Shareholders' Equity296.85M294.7M282.8M-97.94K-83.9K21.03K
Common Stock311.9M309.18M296.74M718718719
Retained Earnings-15.05M-14.48M-13.93M-122.94K-108.9K-3.97K
Treasury Stock000000
Accumulated OCI000000
Minority Interest000000

Key Metrics

Growth RegimeMixed
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Liquidation and deal-sourcing failure

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Dwindling Cash Reserves Threaten Operations

According to the most recent quarterly filings, GPAT's cash position has contracted to $119,400, resulting in a current ratio of 0.17, which suggests that the entity possesses a severely limited buffer to cover ongoing administrative expenses as it approaches its critical business combination deadline.

The sharp decline in the current ratio from 1.76 in 2024Q2 to 0.17 in 2026Q1 indicates that the company is rapidly exhausting its liquid resources. This trend suggests that management may soon require additional capital infusions from the sponsor to maintain basic corporate functions, potentially increasing pressure to finalize a deal prematurely.

Leverage Dynamics Driven by Loans

As reported in financial statements, GPAT's debt load has increased to $515,000 in 2026Q1, reflecting a reliance on sponsor-provided working capital loans that are necessary to sustain the entity's administrative overhead in the absence of any operational revenue streams or independent cash-generating activities.

The accumulation of debt in the form of sponsor loans appears to be a necessity-driven strategy rather than a strategic capital allocation choice. Investors should monitor whether these obligations are converted into equity or repaid upon a successful merger, as they represent a direct claim on the trust's assets.

Equity Erosion Through Accumulated Deficits

Based on GPAT's reported figures, retained earnings have deteriorated to a deficit of $15.0 million as of 2026Q1, signaling that the entity's capital base is being steadily eroded by the ongoing costs of maintaining the shell structure without any offsetting operational income or commercial success.

The persistent negative trajectory in retained earnings underscores the structural challenge of the SPAC model, where administrative costs continuously deplete shareholder equity. This trend suggests that the value of the equity is increasingly tied to the potential of a future acquisition rather than the current book value of the entity.

Restricted Trust Assets Mask Vulnerability

As highlighted in recent SEC filings, the reported total assets of $312.1 million are heavily skewed by restricted funds held in trust, which are legally unavailable for general corporate use, thereby obscuring the company's actual operational fragility and its dependence on external sponsor support.

Analysts should distinguish between the restricted trust assets and the meager operating cash, as the headline asset figure provides a misleading sense of financial security. This structural separation implies that the company's ability to survive until a merger is entirely contingent on the sponsor's willingness to continue funding the operating deficit.

GPAT — Frequently Asked Questions

Quick answers to the most common questions about buying GPAT stock.

What are the total assets of GP-Act III Acquisition Corp. (GPAT)?

As of 2025, GP-Act III Acquisition Corp. (GPAT) had total assets of $309.4M including $0.2M in current assets.

How much debt does GP-Act III Acquisition Corp. (GPAT) have?

GP-Act III Acquisition Corp. (GPAT) carries total debt of $0.4M. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of GP-Act III Acquisition Corp.?

GP-Act III Acquisition Corp. (GPAT) has total shareholders' equity (book value) of $294.7M ($10.25 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is GP-Act III Acquisition Corp.'s current ratio and liquidity?

GP-Act III Acquisition Corp. (GPAT) reported a current ratio of 0.30x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.